| Entry |
|
|---|
| Name |
Levalbuterol hydrochloride (USP);
Xopenex (TN) |
|---|
| Product |
|
|---|
| Generic |
LEVALBUTEROL (A-S Medication Solutions), LEVALBUTEROL (Amneal Pharmaceuticals of New York LLC), LEVALBUTEROL (Aurobindo Pharma Limited), LEVALBUTEROL (Aurobindo Pharma Limited), LEVALBUTEROL (Bryant Ranch Prepack), LEVALBUTEROL (Bryant Ranch Prepack), LEVALBUTEROL (Bryant Ranch Prepack), LEVALBUTEROL (Burel Pharmaceuticals), LEVALBUTEROL (Luoxin Aurovitas Pharma (Chengdu)), LEVALBUTEROL (Mylan Pharmaceuticals), LEVALBUTEROL (Mylan Pharmaceuticals), LEVALBUTEROL (Proficient Rx LP), LEVALBUTEROL (Ritedose Pharmaceuticals), LEVALBUTEROL (Teva Pharmaceuticals USA), LEVALBUTEROL INHALATION (Dr. Reddy's Laboratories), LEVALBUTEROL INHALATION SOLUTION (Sun Pharmaceutical Industries) |
|---|
| Formula |
C13H21NO3. HCl
|
|---|
| Exact mass |
275.1288
|
|---|
| Mol weight |
275.77
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Cardiovascular agent
DG01456 Adrenergic receptor agonist
DG01455 beta-Adrenergic receptor agonist
DG01452 beta2-Adrenergic receptor agonist
|
|---|
| Remark |
| Product (DG01235): | D02281<US> D04703<US> |
|
|---|
| Efficacy |
Antiasthmatic, Bronchodilator, beta2-Adrenergic receptor agonist |
|---|
| Comment |
Phenethylamine derivative
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Interaction |
|
|---|
| Brite |
USP drug classification [BR:br08302]
Respiratory Tract/Pulmonary Agents
Bronchodilators, Sympathomimetic
Levalbuterol
D02281 Levalbuterol hydrochloride (USP)
Drug groups [BR:br08330]
Cardiovascular agent
DG01456 Adrenergic receptor agonist
DG01455 beta-Adrenergic receptor agonist
DG01452 beta2-Adrenergic receptor agonist
DG01235 Levalbuterol
D02281 Levalbuterol hydrochloride
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Adrenaline
ADRB2
D02281 Levalbuterol hydrochloride (USP) <US>
Drug groups [BR:br08330]
Cardiovascular agent
DG01456 Adrenergic receptor agonist
DG01455 beta-Adrenergic receptor agonist
DG01452 beta2-Adrenergic receptor agonist
DG01235 Levalbuterol
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 18
1 C8y C 19.6700 -16.1700
2 C8x C 18.4100 -16.8700
3 C1c C 20.8600 -16.8700
4 C8x C 19.6700 -14.7700
5 C8y C 17.2200 -16.1700
6 C1b C 22.0500 -16.1700
7 O1a O 20.8600 -18.2700
8 C8x C 18.4100 -14.0700
9 C8y C 17.2200 -14.7700
10 C1b C 16.0300 -16.8700
11 N1b N 23.3100 -16.8700
12 O1a O 16.0300 -14.0700
13 O1a O 14.7700 -16.1700
14 C1d C 24.5000 -16.1700
15 C1a C 25.6900 -16.8700
16 C1a C 24.5000 -14.7700
17 C1a C 25.7124 -15.4700
18 X Cl 29.4700 -17.0100
BOND 17
1 1 2 1
2 1 3 1
3 1 4 2
4 2 5 2
5 3 6 1
6 3 7 1 #Down
7 4 8 1
8 5 9 1
9 5 10 1
10 6 11 1
11 9 12 1
12 10 13 1
13 11 14 1
14 14 15 1
15 14 16 1
16 8 9 2
17 14 17 1
|
|---|
